Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

No reported Accounts Receivables figures are available to summarize.

Accounts Receivables history

Currency unavailable · from the cash flow

No Accounts Receivables data reported for this period type.

Accounts Receivables vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Accounts Receivables for ODTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PTGXProtagonist Therapeutics, Inc.LTM Jun 2026$13.42M USD-2409.1%+238.7%4.8%
ANABAnaptysBio, Inc.LTM Mar 2026$7.86M USD+44.2%—3.4%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$6.81M USD+5438.2%+253.5%81.4%
SYRESpyre Therapeutics, Inc.LTM Sep 2026$0 USD——0.0%
ORKAOruka Therapeutics, Inc.LTM Sep 2026$0 USD———
ALMSAlumis Inc. Common StockLTM Jun 2026$0 USD——0.0%
IMUXImmunic, Inc.LTM Mar 2026$0 USD———
ODTXOdyssey Therapeutics, Inc.—— ———
AGMBAgomAb Therapeutics N.V. American Depositary Shares—— ———
Peer median (excluding ODTX) —+44.2%+246.1%3.4%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.